LUCID DIAGNOSTICS INC LUCD
COM · Common Stock · CUSIP 54948X109
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- HeadquartersNew York, NY
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 43.7m as of 2023-08-10, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $1.39.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 24 |
| Q4 2022 | 24 |
| Q1 2023 | 20 |
| Q2 2023 | 19 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 9 | 14 |
| Q1 2023 | 7 | 8 |
| Q2 2023 | 7 | 7 |
Biggest buyers
| GEODE CAPITAL MANAGEMENT, LLC | Added | +101.9k |
| CITADEL ADVISORS LLC | New | +62.5k |
| LUMINUS MANAGEMENT LLC | Added | +23.1k |
| BlackRock Inc. | Added | +7.4k |
| VANGUARD GROUP INC | Added | +400 |
| ROYAL BANK OF CANADA | New | +95 |
| WELLS FARGO & COMPANY/MN | Added | +35 |
Biggest sellers
| Nantahala Capital Management, LLC | Reduced | -62.6k |
| Virtu Financial LLC | Sold out | -15.5k |
| Verition Fund Management LLC | Reduced | -14.3k |
| Tower Research Capital LLC (TRC) | Reduced | -3.1k |
| UBS Group AG | Sold out | -2.6k |
| Belpointe Asset Management LLC | Sold out | -1.5k |
| MORGAN STANLEY | Reduced | -600 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
PAVmed Inc.
13D · may seek influence
-0.8 pts · filed 2026-02-09
Stated purposeThe Reporting Person is the parent company of the Issuer. As a result of its ability to vote 27.5% of the Common Stock (and an estimated 26.3% of all the capital stock of the Issuer), the Reporting Person has the power to significantly influence the election of directors and all other matters that would require the vote of the outstanding shares of capital stock of the Issuer. Subject to the restrictions on transfer described in Item 6, the Reporting Person or any of the Principals, respectively, may acquire additional securities of the Issuer and may sell all or a portion of the securities then held in the open market or in privately negotiated transactions, although none of the Reporting Person or the Principals has any present intention to acquire or sell any securities of the Issuer ex… Full filing |
27.5% |
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Q3 2022 | 0 | — | 1 | $57.7k | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| LUMINUS MANAGEMENT LLC 0.37% of their portfolio | 878.4k $1.2m | Added +23.1k |
| VANGUARD GROUP INC 0.00% of their portfolio | 319.8k $444.6k | Added +400 |
| Nantahala Capital Management, LLC 0.03% of their portfolio | 199.1k $276.7k | Reduced -62.6k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 143.5k $199.4k | Added +101.9k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 135.0k $187.7k | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 62.5k $86.9k | New |
| Verition Fund Management LLC 0.00% of their portfolio | 36.2k $50.3k | Reduced -14.3k |
| Geneos Wealth Management Inc. 0.00% of their portfolio | 33.9k $47.1k | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 26.3k $36.6k | Added +7.4k |
| LPL Financial LLC 0.00% of their portfolio | 14.4k $20.0k | Unchanged |
| STATE STREET CORP 0.00% of their portfolio | 10.5k $14.6k | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 2.0k $2.8k | Unchanged |
| CWM, LLC 0.00% of their portfolio | 1.9k $3.0k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 200 $278 | Reduced -600 |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 95 $0 | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 94 $131 | Added +35 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 27 $38 | Reduced -3.1k |
| HANTZ FINANCIAL SERVICES, INC. 0.00% of their portfolio | 10 $0 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |